0.34Open0.34Pre Close0 Volume19 Open Interest86.00Strike Price0.00Turnover4589.65%IV11.85%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.34Extrinsic Value100Contract SizeAmericanOptions Type0.1106Delta0.0287Gamma227.03Leverage Ratio-484.5986Theta0.0000Rho25.12Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet